Wells Fargo Maintains Overweight on Eli Lilly, Raises Price Target to $1000
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Mohit Bansal maintains an Overweight rating on Eli Lilly (NYSE:LLY) and raises the price target from $875 to $1000.
August 09, 2024 | 3:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Mohit Bansal maintains an Overweight rating on Eli Lilly and raises the price target from $875 to $1000.
The raised price target and maintained Overweight rating from a reputable analyst at Wells Fargo is likely to positively impact Eli Lilly's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100